Evidence map›Paper›PMID 30458880›Full record

Trial reportCritical care (London, England)2018

Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial.

Michael J Massey, Peter C Hou, Michael Filbin, Henry Wang, Long Ngo, David T Huang, William C Aird, Victor Novack, Stephen Trzeciak, Donald M Yealy and 4 more

3 registry-linked trialsOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00510835 nacompletednot on this map

Protocolized Care for Early Septic Shock

TypeinterventionalSponsorUniversity of PittsburghRan2008 to 2013Enrolled1,351ConditionsSepsis, Severe Sepsis, Septic ShockArmsEarly Goal Directed Therapy (EGDT), Protocolized Standard Care (PSC), Usual Care (UC)
NCT02270281 phase4completednot on this map

Dexmedetomidine Improve Microcirculatory Alterations in Initial Resuscitated Septic Shock Patients

TypeinterventionalSponsorSoutheast University, ChinaRan2014 to 2017Enrolled44ConditionsSeptic ShockArmsDexmedetomidine 0.7 Mcg/kg/h
NCT05180409 unknown statusnot on this mapstarted 2020, after this paper: background citation

The Prognostic Value of Simultaneous Assessment of Microcirculation Alteration With Sublingual Microcirculation and Near-infrared Spectroscopy on the Acute Respiratory Distress Syndrome of Various Phenotypes

TypeobservationalSponsorChang Gung Memorial HospitalRan2020 to 2022Enrolled60ConditionsAcute Respiratory Distress Syndrome
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Systemic and Cardiac Microvascular Dysfunction in Hypertension.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Michael J MasseyDepartment of Emergency Medicine and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, 1 Deaconess Road, CC2-W, Boston, MA, 02215, USA.
Peter C HouDepartment of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Michael FilbinDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.
Henry WangDepartment of Emergency Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Long NgoDivision of General Medicine, Department of Medicine, Beth Isarel Deaconess Medical Center, Boston, MA, USA.
David T HuangDepartment of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
William C AirdDivision of Molecular Medicine, Department of Medicine, and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Victor NovackClinical Research Center, Soroka University Medical Center, Be'er-Sheva, Israel.
Stephen TrzeciakCenter for Critical Care Services, Cooper University Hospital, Camden, NJ, USA.
Donald M YealyDepartment of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
John A KellumDepartment of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Derek C AngusDepartment of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Nathan I ShapiroDepartment of Emergency Medicine and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, 1 Deaconess Road, CC2-W, Boston, MA, 02215, USA. nshapiro@bidmc.harvard.edu.ORCID http://orcid.org/0000-0003-3508-4390
ProCESS investigators
Beth Israel Deaconess Medical Center · USUniversity of Pittsburgh · USBrigham and Women's Hospital · USDeaconess Hospital · USSoroka Medical Center · ILUniversity of Alabama at Birmingham · US

Funding

Protocolized Care for Early Septic Shock (ProCESS)P50GM076659 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANGUS, DEREK C · 2006 to 2012
$11.2M
Endothelial Cell Signaling and Microcirculatory Flow in Severe SepsisR01HL091757 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SHAPIRO, NATHAN I · 2008 to 2011
$2.0M
National Heart, Lung, and Blood Institute R01 HL091757National Institute of General Medical Sciences P50 GM076659NHLBI NIH HHS R01 HL091757NIGMS NIH HHS P50 GM076659
6 · The paper itself

Abstract

backgroundWe sought to determine the effects of alternative resuscitation strategies on microcirculatory perfusion and examine any association between microcirculatory perfusion and mortality in sepsis.

methodsThis was a prospective, formally designed substudy of participants in the Protocolized Care in Early Septic Shock (ProCESS) trial. We recruited from six sites with the equipment and training to perform these study procedures. All subjects were adults with septic shock, and each was assigned to alternative resuscitation strategies. The two main analyses assessed (1) the impact of resuscitation strategies on microcirculatory perfusion parameters and (2) the association of microcirculatory perfusion with 60-day in-hospital mortality. We measured sublingual microcirculatory perfusion using sidestream dark field in vivo video microscopy at the completion of the 6-h ProCESS resuscitation protocol and then again at 24 and 72 h.

resultsWe enrolled 207 subjects (demographics were similar to the overall ProCESS cohort) and observed 40 (19.3%) deaths. There were no differences in average perfusion characteristics between treatment arms. Analyzing the relationship between microcirculatory perfusion and mortality, we found an association between vascular density parameters and mortality. Total vascular density (beta = 0.006, p < 0.003), perfused vascular density (beta = 0.005, p < 0.04), and De Backer score (beta = 0.009, p < 0.01) were higher overall in survivors in a generalized estimating equation model, and this association was significant at the 72-h time point (p < 0.05 for each parameter).

conclusionsMicrocirculatory perfusion did not differ between three early septic shock treatment arms. We found an association between microcirculatory perfusion parameters of vascular density at 72 h and mortality.

trial registrationClinicalTrials.gov, NCT00510835 . Registered on August 2, 2007.

Indexed as

AdultAgedCohort StudiesFemaleHemodynamicsHumansMaleMicrocirculationMiddle AgedOrgan Dysfunction ScoresProspective StudiesResuscitationShock, SepticMicrocirculationMortalityPathophysiologySepsis

Identifiers

PMID30458880
PMCPMC6245723
OpenAlexW2900845672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.